Sort   by:  
 Page size 
UnknownThe antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination.
Current seasonal and pre-pandemic influenza vaccines induce short-lived predominantly strain-specific and limited heterosubtypic responses. To better understand how vaccine adjuvants AS03 and MF59 may provide improved antibody responses to vaccination, we interrogated serum from subjects who receive...
S-EPMC9427073 | biostudies-literature
UnknownVaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cells.
COVID-19 has caused significant morbidity and mortality worldwide but also accelerated the clinical use of emerging vaccine formulations. To address the current shortcomings in the prevention and treatment of SARS-CoV-2 infection, this study developed a novel vaccine platform that closely mimics den...
S-EPMC9933546 | biostudies-literature
UnknownEvaluation of Four Adjuvant Combinations, IVAX-1, IVAX-2, CpG-1826+Montanide ISA 720 VG and CpG-1018+Montanide ISA 720 VG, for Safety and for Their Ability to Elicit Protective Immune Responses in Mice against a Respiratory Challenge with Chlamydia muridarum.
There is an urgent need to produce a vaccine for Chlamydia trachomatis infections. Here, using the Chlamydia muridarum major outer membrane protein (MOMP) as an antigen, four adjuvant combinations IVAX-1 (MPLA+CpG-1018+AddaVax), IVAX-2 (MPLA+CpG-1018+AS03), CpG-1826+Montanide ISA 720 V...
S-EPMC10383793 | biostudies-literature
UnknownCommon asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination.

Background

Despite largely successful control efforts, malaria remains a significant public health problem in Thailand. Based on microscopy, the northwestern province of Tak, once Thailand's highest burden area, is now considered a low-transmission region. However, microscopy is insensitive ...
S-EPMC4918199 | biostudies-literature
ProteomicsAntibody profiling of smallpox vaccinees with/without a 'take' using custom vaccinia virus proteome microarrays
Successful vaccination against smallpox with conventional vaccinia virus is usually determined by the development of a vesicular skin lesion at the site of vaccinia inoculation, called a ‘take’. Although previous vaccination is known to be associated with attenuation of the take, the immunology t...
ORGANISM(S): Homo sapiens 
2012-01-09 | E-GEOD-34931 | biostudies-arrayexpress
Sort   by:  
 Page size